Whitepapers/App Notes/Posters

Whitepaper: Handheld analyzers for the screening of pharmaceutical counterfeits

Posted: 1 October 2013 |

Counterfeit and substandard medicines have serious human health and economic costs…

The magnitude of the counterfeit and substandard pharmaceutical problem has recently gained significant public attention due to a number of high profile incidents and greater media focus. The World Health Organization (WHO) estimates that up to 10% of the world’s drugs are substandard or counterfeit and are expected to reach $75B. Even more significantly, it is estimated that 700,000 lives will be lost each year due to counterfeit malaria and tuberculosis drugs alone (International Policy Network, 2009).

This whitepaper is restricted - login or subscribe free to access

EPR Issue #2 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • bi-monthly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 

Send this to a friend